Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’s board of directors unanimously rejected the proposal, saying that the merger substantially undervalues the company and its future growth prospects.
GW Pharmaceuticals Receives Orphan Drug Designation For Cannabidiol Treatment of Neonatal Hypoxic-Ischemic EncephalopathyApril 24, 2015 11:15 am | by Globe Newswire | News | Comments
There are currently no FDA-approved medicines specifically indicated for NHIE.
Anglo-Swedish drug-maker AstraZeneca PLC reported a 7 percent fall in net profit for the first...
Shares of Aerie Pharmaceuticals lost two-thirds of their value in after-market trading after the...
Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.
Catalent announced that it has received a significant project grant as part of a consortium looking to evaluate, develop and manufacture thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.
The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.
The market for other rheumatoid arthritis therapeutics is considerable as many patients do not respond well to TNF inhibitors.
Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial infarction, stent thrombosis, and stroke because of insufficient clopidogrel-induced platelet inhibition.
Pfizer said that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.
Capricor Therapeutics, Inc. today announced that it has been granted orphan drug designation by FDA for its cell therapeutic product candidate, CAP-1002, for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD).
Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration.
Vical Incorporated today announced that it has entered into a $4 million contract with the IPPOX Foundation to manufacture HIV-antigen plasmid DNA as a component of vaccine regimens to be evaluated in clinical trials for the prevention of HIV infection.
The Roche Group posted strong sales growth in the first three months in both divisions, with demand for oncology and immunology medicines driving growth in pharmaceuticals, and immunodiagnostics products driving growth in diagnostics.
Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.
GW Pharmaceuticals announced today that it has initiated the second Phase 3 clinical trial of Epidiolex(R) (cannabidiol or CBD) for the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy.
ESCMID warns that Europe may surpass one million deaths due to ineffective antibiotics by 2025.
ITT Corporation is showcasing its highly engineered valve technologies and solutions at Interphex, one of the world's largest trade shows for the biopharmaceutical industry.
For the first time, the company will also be presenting a polymer prefillable syringe for sensitive drugs – the new SCHOTT TopPac SD.
A startup company that’s found a unique niche in the exploding cannabis industry, Potbotics uses robotic technology to bring medical marijuana use into a new era of high-tech pharma.
The medical and recreational marijuana stores industry has reached new highs, riding a wave of legalization to become one of the fastest growing industries in the United States.
CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.
Inovio Pharmaceuticals, Inc. announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis B.
ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.
The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.
Growing costs have been attributed to a slow FDA, drug complexity, and short patent life.
Mylan Executive Chairman Robert J. Coury commented, "We note that there has been some media speculation with regard to a potential bid for Mylan by Teva and that this rumor has been circulating for some time."
Applied Genetic Technologies Corporation and 4D Molecular Therapeutics, leaders in next-generation adeno-associated virus gene therapy vector discovery and product development, today announced a collaboration and license agreement to discover and develop optimized AAV vectors to treat specific ophthalmic disease indications with high unmet medical need.
- Page 1